Miwa Yoshida (registration number: 18189)
April 2012: Registered as a patent attorney; February 2014: Appended for representation in specific infringement litigation
Languages: Japanese(native), English(business), Russian(beginner)
Background:
Graduated from College of Arts and Sciences, University of Tokyo BSc (molecular cell biology)
-Thesis: “Analysis of MP (movement protein) of chimera TMV which lacks the ability of moving through cells”
Graduated from Graduate School of Arts and Sciences, University of Tokyo MSc (cell biology)
-Master’s thesis, “Isolation of plastid nucleoids of Cyanophora paradoxa and analysis of their protein composition”
4 years of experience as an IT engineer at IBM Japan Systems Engineering Co., Ltd.
For a total of 12 years of experience at Aoyama and Partners, Iwatani International Patent Office, Kitahama Partners, Kaneka Corporation, and iPS Academia Japan, Inc. (Technology Licensing Organization), mainly patent prosecution n the fields of biotechnology and chemistry and trademark prosecution.
April 2022- In charge of general intellectual property affairs, Rege Nephro Co., Ltd.
Activities in the industry, affiliated organizations:
- Japan Patent Attorneys Association (Kansai-kai)
- Cellular Agriculture Institute of the Commons (CAIC) -Affiliate Member
- International Association for the Protection of Industrial Property (AIPPI JAPAN)
- Japan Intellectual Property Association: Special Committee International 1st Committee (retired in the middle of the term) until September of 2019
- Japan Intellectual Property Association: E05 course “Negotiation and drafting in English contract” completed in 2018
- Completed Japan Intellectual Property Association 2017 F02 Course “Training on the U.S. Patent System and Mock Trial, IPR, etc.” – “IoT-Related Applications and U.S. Patent Law Section 101 (Subject Matter Eligibility),” Intellectual Property Management, Vol. 68 No. 7 (2018) 974-988
- Japan Patent Attorneys Association, Bio-Life Sciences Committee, 2014 and 2015 – “Investigation, Research and Proposal on Bio-Intellectual Property from Bio-Startups” (Subcommittee 6) in 2015 – “Investigation and Research on International Competitiveness of Japanese Bio-Life Sciences Industry from Patent Aspect” (Subcommittee 3) in 2014
Other seminars and qualifications:
2021: Pharmaceutical Medicine Course recognized by the Japanese Association of Pharmaceutical Medicine and certified by the PharmaTrain Federation as a Centre of Excellence
2019: LSE MBA Essentials
2019: Osaka University Development of problem-solving capability in health and medical fields
TOEIC 900 points, IELTS 6.5, Intellectual Property Management Skills Test Level 1 (Patents and Brands), Business Practice Legal Test Level 2, Registered Seller, Russian Language Proficiency Test Level 4
